跳至主要内容
临床试验/NCT01779609
NCT01779609已完成4 期

Effect of a Dual ET(Endothelin)-Blocker on Exercise Induced Vascular Adaptations in Type 2 Diabetes Mellitus (T2DM)

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
19
试验地点
1
主要终点
Flow mediated dilation

研究概览

简要总结

The purpose of this study is to establish the effect of ET blockade on vascular adaptations during an 8-week exercise program in subjects with T2DM. We hypothesize that combining ET - blockade with exercise training leads to an acute increase of exercise induced blood flow when compared with exercise alone. We expect that this will lead to an optimization of vascular training effect in T2DM.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Type 2 Diabetes Mellitus (>2 years since diagnosis) OR controls

排除标准

  • <40 years of age
  • >65 years of age
  • cardiovascular disease
  • diabetes related manifest vascular complications
  • Type 1 Diabetes Mellitus
  • use of Glibenclamide
  • use of HIV drugs
  • use of calcineurin inhibitors
  • use of drugs that interfere with CYP3A4 and CYP2C19

研究组 & 干预措施

Bosentan + Exercise

Experimental

2x/day 62.5 mg Bosentan for 4 weeks alongside 3x/week supervised exercise 2x/day 125 mg Bosentan for 4 weeks alongside 3x/week supervised exercise

干预措施: Bosentan (Drug)

Bosentan + Exercise

Experimental

2x/day 62.5 mg Bosentan for 4 weeks alongside 3x/week supervised exercise 2x/day 125 mg Bosentan for 4 weeks alongside 3x/week supervised exercise

干预措施: Exercise (Behavioral)

Placebo + Exercise

Placebo Comparator

2x/day 62.5 mg Placebo for 4 weeks alongside 3x/week supervised exercise 2x/day 125 mg Placebo for 4 weeks alongside 3x/week supervised exercise

干预措施: Placebo (Drug)

Placebo + Exercise

Placebo Comparator

2x/day 62.5 mg Placebo for 4 weeks alongside 3x/week supervised exercise 2x/day 125 mg Placebo for 4 weeks alongside 3x/week supervised exercise

干预措施: Exercise (Behavioral)

Exercise

Other

3x/week supervised exercise for 8 weeks

干预措施: Exercise (Behavioral)

结局指标

主要结局

Flow mediated dilation

时间窗: 8 weeks

次要结局

  • Maximal Oxygen Uptake(8 weeks)
  • Intima-Media Thickness(8 weeks)
  • Conduit Artery Dilator Capacity(8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

ET-blockade and Exercise-induced Vascular... | 临床试验